RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      IIIB 병기 비소세포 폐암의 방사선치료 성적 = Results of Radiation Therapy in Unresectable Non-Small Cell Lung Cancer

      한글로보기

      https://www.riss.kr/link?id=A19591524

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      To evaluate the effect of radiation therapy in nonsmall cell lung cancer stage IIIB, we analyzed the 23 patients diagnosed NSCLC IIIB and treated curatively with radiation therapy between September 1989 and March 1993 at the department of therapeutic radiology, Chungnam National University Hospital, retrospectively. The actuarial 1 year survival rate was 39.2%, 2 year survival rate was 2.3%, and median survival time was 10 months. The difference of survival rates by performance status, response to radiotherapy, T stage, N stage, tumor size, age, pathologic cell type, combination with chemotherapy was not statistically significant. To increase the survival time and rate of the patients with NSCLC IIIB, further study for adequate radiation fractionation and dose, combination with chemoherapy and surgery will be needed.
      번역하기

      To evaluate the effect of radiation therapy in nonsmall cell lung cancer stage IIIB, we analyzed the 23 patients diagnosed NSCLC IIIB and treated curatively with radiation therapy between September 1989 and March 1993 at the department of therapeutic ...

      To evaluate the effect of radiation therapy in nonsmall cell lung cancer stage IIIB, we analyzed the 23 patients diagnosed NSCLC IIIB and treated curatively with radiation therapy between September 1989 and March 1993 at the department of therapeutic radiology, Chungnam National University Hospital, retrospectively. The actuarial 1 year survival rate was 39.2%, 2 year survival rate was 2.3%, and median survival time was 10 months. The difference of survival rates by performance status, response to radiotherapy, T stage, N stage, tumor size, age, pathologic cell type, combination with chemotherapy was not statistically significant. To increase the survival time and rate of the patients with NSCLC IIIB, further study for adequate radiation fractionation and dose, combination with chemoherapy and surgery will be needed.

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼